SphingoGene, Inc.
PrivateCompany Overview
SphingoGene, Inc. operates in Healthcare & Life Sciences and is based in Mount Pleasant, South Carolina. It was founded in 2006.
SphingoGene, Inc. is a biotechnology company that develops small molecule therapeutics for cancer treatment by targeting sphingolipid metabolism.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SphingoGene, Inc. Comparables
Compare SphingoGene, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CerRx | 81% | |
| Lipo-Immuno Tech | 80% | |
| Pendrea Bio, Inc. | 80% |
For institutional investors. Book with your work email.
SphingoGene, Inc. Funding Rounds
Historical fundraising activity
SphingoGene, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SphingoGene, Inc.'s valuation, stock price, and market status.
Is SphingoGene, Inc. a public or private company?
SphingoGene, Inc. is a private company.
What is the current stock price of SphingoGene, Inc.?
SphingoGene, Inc. is a private company, so its shares have no public market price. Caplight tracks SphingoGene, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SphingoGene, Inc. worth (valuation)?
Valuation information for SphingoGene, Inc. is not publicly available.
Can I buy SphingoGene, Inc. stock?
SphingoGene, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SphingoGene, Inc.'s last funding round?
Funding round information for SphingoGene, Inc. is not publicly available.
Who are the main investors in SphingoGene, Inc.?
Investor information for SphingoGene, Inc. is not publicly disclosed.
Will SphingoGene, Inc. IPO soon?
No public IPO plans have been announced for SphingoGene, Inc..
How can I track SphingoGene, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in SphingoGene, Inc.'s shares on secondary markets.